InsidersTradesSigma
Track the Polaryx Therapeutics, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). The latest transaction was reported on 20 February 2026 (Acquisition). Among the most active insiders: Landis G. Michael. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Polaryx Therapeutics, Inc. 是一家生物制药公司，专注于开发罕见疾病的创新疗法。该公司在纳斯达克上市，股票代码为 PLYX。